N.º de artículoCLM-10025-PK

25-Hydroxyvitamin D₃ (23,24,25,26,27-¹³C₅, 99%) CP 95%

HazardousImage
Sinónimos(εR,1R,3αS,4E,7αR)-1H-Indene-1-pentanol, octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-ε,7a-dimethyl-α,α-di(methyl-d3)-, hydrate (1:1) ; 25-Hydroxycholecalciferol monohydrate; (3β,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, hydrate (1:1); Calcifediol monohydrate
FórmulaC22*C5H44O2
CAS Número Lebeled2785319-22-2
CAS Número Unlabeled19356-17-3
Número CE

Propiedades

Peso molecular
Pureza95%
FormularioIndividual
ConcentraciónNeat
Aplicación(es)Clinical MS, Metabolism, Metabolomics
Temperatura de almacenamientoStore in freezer (-20°C). Protect from light.

Información de seguridad

Hazard Pictograms
HazardousImageHazardousImage
Signal WordDanger
Hazard StatementToxic if swallowed or in contact with skin, Fatal if inhaled., Causes damage to organs (Respiratory tract) through prolonged or repeated exposure (Dermal, Inhalation, oral).

Comentarios (0)

Todavía no hay comentarios.

N.º de artículoCLM-10025-PK

25-Hydroxyvitamin D₃ (23,24,25,26,27-¹³C₅, 99%) CP 95%

HazardousImage
Dry ice shipment required.
Sinónimos(εR,1R,3αS,4E,7αR)-1H-Indene-1-pentanol, octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-ε,7a-dimethyl-α,α-di(methyl-d3)-, hydrate (1:1) ; 25-Hydroxycholecalciferol monohydrate; (3β,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, hydrate (1:1); Calcifediol monohydrate
FórmulaC22*C5H44O2
CAS Número Lebeled2785319-22-2
CAS Número Unlabeled19356-17-3
Número CE

Propiedades

Peso molecular
Pureza95%
FormularioIndividual
ConcentraciónNeat
Aplicación(es)Clinical MS, Metabolism, Metabolomics
Temperatura de almacenamientoStore in freezer (-20°C). Protect from light.

Información de seguridad

Hazard Pictograms
HazardousImageHazardousImage
Signal WordDanger
Hazard StatementToxic if swallowed or in contact with skin, Fatal if inhaled., Causes damage to organs (Respiratory tract) through prolonged or repeated exposure (Dermal, Inhalation, oral).

Comentarios (0)

Todavía no hay comentarios.